FIELD: chemistry.
SUBSTANCE: present invention relates to immunology. Antibody specifically binding to human CD26, as well as nucleic acids encoding such an antibody, an expression vector, a host cell, and a method for producing an antibody. In addition, an antibody that specifically binds to human CD26, compositions and a kit are described.
EFFECT: present invention can be used to stimulate engraftment of a graft after transplantation of hematopoietic stem cells, prevention or treatment of graft versus host disease (GvHD), including the prevention or treatment of aplastic anemia.
31 cl, 12 dwg, 12 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MONOCLONAL ANTIBODIES AGAINST IL-21 OF HUMAN BEING | 2008 |
|
RU2504552C2 |
| APPLICATION OF ANTI-CD40-ANTIBODIES | 2006 |
|
RU2442606C2 |
| ANTAGONIST ANTI-IL-7 RECEPTOR ANTIBODIES AND METHODS | 2011 |
|
RU2533809C9 |
| ANTI-PD-1 ANTIBODIES | 2015 |
|
RU2711141C2 |
| ANTIBODIES AGAINST PD-1 AND THEIR USE | 2018 |
|
RU2788616C2 |
| ANTIBODIES AGAINST αβTCR | 2012 |
|
RU2630656C2 |
| NEW MONOCLONAL ANTIBODIES TO PROGRAMMED CELL DEATH 1 (PD-1) PROTEIN | 2016 |
|
RU2757316C2 |
| HUMANISED ANTI-LIGHT ANTIBODIES AND USING THEM | 2010 |
|
RU2542394C2 |
| HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS | 2013 |
|
RU2628305C2 |
| ANTI-C5a ANTIBODIES AND THEIR APPLICATIONS | 2018 |
|
RU2773779C2 |
